
Managing Multidrug Resistance in Cancer
Plant-derived compounds and nanotechnology converge to combat drug-resistant cancers Over 90% of cancer deaths in metastatic cases are linked to drug resistance, yet few references integrate phytochemical therapeutics with nanotechnology-based delivery. Managing Multidrug Resistan......
fra 2 129,-
På lager i 1 butikker
Kjøp på nett
På lager
Frakt og levering
Produktinformasjon
<p><b>Plant-derived compounds and nanotechnology converge to combat drug-resistant cancers</b> <p>Over 90% of cancer deaths in metastatic cases are linked to drug resistance, yet few references integrate phytochemical therapeutics with nanotechnology-based delivery. <i>Managing Multidrug Resistance in Cancer: Emerging Mechanisms and Plant-based Strategies</i> assembles expert contributors who critically evaluate preclinical and clinical evidence on plant-derived molecules that inhibit efflux pumps, restore apoptosis, and reverse resistance in breast, lung, colorectal, ovarian, and hematologic malignancies. <p>Contributors detail nanotechnology-based biodegradable delivery systems that enhance selectivity, bioavailability, and retention time while reducing toxicity. The volume covers AI and machine-learning tools for diagnostic improvement, personalized medicine frameworks, and clinical trial data on phytochemical efficacy. Global MDR cancer scenarios in both developed and developing nations receive dedicated analysis, addressing accessibility and economic feasibility of plant-derived treatments. <p>Key topics also include: <ul> <li>Mechanisms of intrinsic and acquired resistance to tamoxifen, EGFR-TKIs, and platinum-based chemotherapeutics across common cancer types</li> <li>Structural diversity and multi-target action of phytochemicals that distinguish them from single-target synthetic agents in MDR reversal</li> <li>Nanocarrier design principles for enhancing solubility, tumor targeting, and controlled release of plant-derived anticancer compounds</li> <li>Translational pathways from preclinical phytochemical research to clinical application, including current trial methodologies and outcomes</li> <li>Toxicity reduction strategies that integrate natural compounds into advanced therapeutic platforms for improved patient survival rates</li> </ul> <p>Designed for researchers and clinicians at the intersection of oncology, pharmacology, and nanotechnology, this volume serves cancer scientists, pharmacognosy specialists, and biomedical professionals seeking low-toxicity treatment approaches. Pharmaceutical developers exploring translational applications of phytochemicals and nanocarriers in precision oncology will find targeted, evidence-based guidance throughout.
Topplisten: Other Brand Bøker
Spesifikasjon
| Produkt | |
|---|---|
| Produktnavn | Managing Multidrug Resistance in Cancer |
| Merke | Other Brand |
FAQ
Black Friday er fredag 27. november 2026. Sammenlign prisen på Managing Multidrug Resistance in Cancer hos flere butikker, og sjekk prishistorikken der den er tilgjengelig. Kontroller at tilbudene gjelder samme modell og variant, og ta med fraktkostnaden når du sammenligner.
Pris og prishistorikk
Akkurat nå er 2 129,- den billigste prisen for Managing Multidrug Resistance in Cancer blant 1 butikker hos Prisradar. Sjekk også vår topp 5-rangering av beste bøker for å være sikker på at du gjør det beste kjøpet.
Martha's Flowers A Practical Guide to Growing, Gathering, and EnjoyingOne for the RoadMy Wobbly ToothStatistical Design and Analysis of Experiments
Bibelen med klistremerker det gamle testamentetFokus: barn, krenkelser, tro hvem er jeg i møte med barn?Quant ‘Breathtakingly readable, recalls Donna Tartt at her best’ Stephen KingThe Americas A New History of the Western Hemisphere
Quant ‘Breathtakingly readable, recalls Donna Tartt at her best’ Stephen KingLive Laugh SpyWhy Religion Is Good for American DemocracyThe Dirty Bicker Princeton, the Jews, and the Scandal of 1958













